Offering a critical analysis of Canada’s access and reimbursement environment, and in-depth discussions on how to adapt market access strategies — especially at a time when affordability and overall health system sustainability are top of mind.

Speaker Name

Farah Husein

Director, Evidence Generation, Medical & Scientific Affairs
Takeda Canada Inc.

Speaker Name

Don Husereau

Adjunct Professor of Medicine
University of Ottawa

Speaker Name

Farah Jivraj

Head, Market Access and Stakeholder Relations

Speaker Name

Andrea Masters

Director, Strategic Access and Pricing Lead


Practitioners at every level with experience in:

  • Pricing
  • Reimbursement
  • Market access
  • Patient access
  • Government and regulatory affairs
  • Health economics
  • Research and development
  • Policy and compliance
  • Pharmacy services
  • Marketing
  • National trade
  • Formularies
  • Business development
  • Sales

From brand generic and manufacturing companies involved in:

  • Product development
  • Public drug programs
  • Pharmaceutical benefits
  • Pharmaceutical strategy
  • Drug submissions
  • Formulary management
  • Policy and economic analysis
  • Provider services and
  • relations
  • Pharmacy

And representatives from:

  • Associations
  • Patient Advocacy Groups
About this Conference

The COVID-19 pandemic has exacerbated time and budgetary constraints leaving market access strategies in a precarious place. At the same time, the National Pharmacare program and PMPRB reforms continue to unfold slowly, with many questions yet to be answered about how these pieces will form a cohesive approach to improved access and affordability without sacrificing innovation.

This annual forum will host critical conversations, examining the most vexing questions and challenges hovering over manufacturers, payers, and patient groups alike, while also exploring opportunities to empower decision-making so that the right treatment reaches patients at the right time.

Join us at this highly anticipated market access event to share best practices, participate in candid discussions, and hear the latest developments from leading drug manufacturers and other industry leaders.


Webinar Recording

PMPRB Modernization and New Regulations: How to Navigate the Transition into a New Regulatory Regime for Drug Pricing in Canada

Quote Icon

Great overview, gave me a different perspective. Got me thinking differently.

Team Lead, Pricing and Contracts, GSK
Quote Icon

I liked the quality of the speakers.

Manager, Market Access and HTA, BMS
Quote Icon

Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.

Manager, Pricing and Contracts, Astellas:
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image